Pharmaceutical products in   Canada

Overview In December 2024 Canada's Pharmaceutical products exports accounted up to C$799M and imports accounted up to C$2.11B, resulting in a negative trade balance of C$1.31B. Between December 2023 and December 2024 the exports of Canada's   Pharmaceutical products have increased by C$236M (41.8%) from C$563M to C$799M, while imports decreased by C$-71.5M (-3.28%) from C$2.18B to C$2.11B.

Destinations In December 2024, Pharmaceutical products were exported mostly to United States (C$553M), Japan (C$60.3M), China (C$16.8M), Italy (C$13.9M), and South Africa (C$13.2M), and were imported mostly from United States (C$697M), Germany (C$268M), Ireland (C$196M), Belgium (C$143M), and Switzerland (C$106M).

Growth In December 2024, the increase in Pharmaceutical products's year-by-year exports was explained primarily by an increase in exports to Belgium (C$23.5M or 215%), Portugal (C$10M or 177k%), and Germany (C$2.38M or 111%). In December 2024, the decrease in Pharmaceutical products's year-by-year imports was explained primarily by a decrease in imports from Switzerland (C$-75.4M or -34.3%), Sweden (C$-62.4M or -58%), and Belgium (C$-52.6M or -52.1%).